| Literature DB >> 22482136 |
Brenda C Kluhsman1, Eugene J Lengerich, Linda Fleisher, Electra D Paskett, Suzanne M Miller-Halegoua, Andrew Balshem, Marcyann M Bencivenga, Angela M Spleen, Paulette Schreiber, Mark B Dignan.
Abstract
INTRODUCTION: The Appalachian region of the United States has disproportionately high colorectal cancer (CRC) death rates and low screening rates. The purpose of this pilot study was to assess acceptability of a take-home fecal immunochemical test (FIT) and the effect of follow-up telephone counseling for increasing CRC screening in rural Appalachia.Entities:
Mesh:
Year: 2012 PMID: 22482136 PMCID: PMC3392085
Source DB: PubMed Journal: Prev Chronic Dis ISSN: 1545-1151 Impact factor: 2.830
Characteristics of Primary Care Patients Recruited for FIT Screening, Appalachian Pennsylvania, 2008-2009
|
| Study Sample, n (%) (N = 200) | FIT Completed, n (%) (n = 145) | FIT Not Completed; Offered Telephone Counseling, n (%) (n = 55) | Unadjusted | Adjusted |
|---|---|---|---|---|---|
|
| |||||
| Male | 50 (25.0) | 29 (20.0) | 21 (38.2) | .01 | .50 |
| Female | 150 (75.0) | 116 (80.0) | 34 (61.8) | ||
|
| 61 (7.8) | 61 (7.8) | 61 (8.0) | .09 | .14 |
|
| |||||
| <High school | 22 (11.1) | 11 (7.6) | 11 (20.8) | .03 | .21 |
| High school | 93 (47.0) | 72 (49.7) | 21 (39.6) | ||
| Some college | 83 (41.9) | 62 (42.8) | 21 (39.6) | ||
|
| |||||
| Married | 132 (66.7) | 99 (68.3) | 33 (62.3) | .41 | .63 |
| Divorced/separated | 28 (14.1) | 22 (15.2) | 6 (11.3) | ||
| Widowed | 23 (11.6) | 16 (11.0) | 7 (13.2) | ||
| Never married | 10 (5.1) | 5 (3.5) | 5 (9.4) | ||
| Living with someone | 5 (2.5) | 3 (2.1) | 2 (3.8) | ||
|
| |||||
| <15,000 | 46 (25.4) | 26 (19.9) | 20 (40.0) | .02 | .16 |
| 15,000-74,999 | 116 (64.1) | 91 (69.5) | 25 (50.0) | ||
| ≥75,000 | 19 (10.5) | 14 (10.70) | 5 (10.0) | ||
|
| |||||
| Insured | 176 (88.9) | 133 (92.4) | 43 (79.6) | .04 | .06 |
| Uninsured | 19 (9.6) | 10 (6.9) | 9 (16.7) | ||
| Don't know | 3 (1.5) | 1 (0.7) | 2 (3.7) | ||
|
| |||||
| Yes | 52 (30.4) | 39 (30.2) | 13 (31.0) | .71 | .81 |
| No | 5 (2.9) | 3 (2.3) | 2 (4.7) | ||
| Don't know | 114 (66.7) | 87 (67.4) | 27 (64.3) | ||
Abbreviations: FIT, fecal immunochemical test; SD, standard deviation.
Calculated by using χ2 and Cochran Mantel Haenszel tests.
Adjusted for location and calculated by using Cochran Mantel Haenszel test.
Calculated for categories of age (50-64 y, 65-74 y, 75-84 y, ≥85y).
Barriers Associated With FIT Nonadherence Among Primary Care Patients (n = 55) in Appalachian Pennsylvania, 2008-2009
|
| Odds Ratio (95% CI) |
|---|---|
|
| |
| CRC screening benefits do not outweigh test difficulties. | 6.15 (2.37-15.99) |
| A normal test result does not lessen the need to worry about developing CRC. | 3.00 (1.47-6.10) |
| Early detection does not make CRC easier to treat. | 2.54 (1.03-6.30) |
| Screening might be physically uncomfortable. | 2.05 (1.01-4.15) |
|
| |
| The screening test is too difficult to understand. | 2.75 (1.05-7.20) |
Abbreviations: FIT, fecal immunochemical test; CI, confidence interval.
More than 1 reported barrier per respondent was possible.
Derived from barriers reported at baseline, controlling for study site and insurance status. The comparison group was patients who initially completed the FIT as recommended by their physician.